PlainRecordsCarboplatin Injection
Also listed by FDA as Kyxata
On FDA's list as current shortage and to be discontinued: 35 packages from 9 companies. Last updated by FDA Nov. 9, 2026. Data from openFDA as of Nov. 12, 2026; FDA's own database can be newer. Not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.
12 of 29 packages on FDA's current shortage list are listed as unavailable; 8 limited, 9 available.
Reason FDA gives most often: “Other” (10 of 29). Check with your pharmacy: FDA's list is national.Current shortage (29)
● available · ◐ limited · ○ unavailable
| Strength | Companies and FDA's availability |
|---|---|
| 9.23077 mg/mLSizes: 65 mL | ◐ Gland Pharma Limited, limited |
| 10 mg/mLSizes: 5 mL, 8 mL, 15 mL, 45 mL, 50 mL, 60 mL | ● Teyro Labs×4, available● Avyxa Pharma, LLC×2, available● Eugia US LLC, available● Gland Pharma Limited, available● Teva Pharmaceuticals USA, Inc., available◐ Hospira, Inc., a Pfizer Company×4, limited◐ Teva Pharmaceuticals USA, Inc.×2, limited◐ Gland Pharma Limited, limited○ Accord Healthcare Inc.×4, unavailable○ Hospira, Inc., a Pfizer Company×4, unavailable○ Eugia US LLC, unavailable○ Fresenius Kabi USA, LLC, unavailable○ Gland Pharma Limited, unavailable○ Teva Pharmaceuticals USA, Inc., unavailable |
Each chip is a company as FDA names it, marked with FDA's availability value for its packages of that strength (×N: N packages; point at a chip for FDA's package texts). Strengths are read from FDA's package text, one row an amount ("10 mg/1 mL" and "50 mg/5 mL (10 mg/mL)" are one row, 10 mg/mL), in the unit FDA wrote; where FDA gives only an amount per volume, the amount per mL is worked out ("5 g/100 mL" is 50 mg/mL); the package sizes are listed under each strength.
By company: availability, FDA's notes and contact
Hospira, Inc., a Pfizer Company
8 packages: 4 limited · 4 unavailable · contact 844-646-4398
Reason “Demand increase for the drug”
Reason “Other”
FDA's note “Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay”
FDA's note “Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027”
FDA's note “Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay”
FDA's note “Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay”
FDA's note “Next Delivery: December 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay”
FDA's note “Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay”
Accord Healthcare Inc.
4 packages: 4 unavailable · contact 866-941-7875, option 2
Reason “Discontinuation of the manufacture of the drug”
FDA's note “Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA”
Gland Pharma Limited
4 packages: 1 available · 2 limited · 1 unavailable · contact Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
Reason “Demand increase for the drug”
Reason “Discontinuation of the manufacture of the drug”
FDA's note “Discontinued; Distributed by BPI Labs, LLC”
FDA's note “Distributed by BPI Labs, LLC”
FDA's note “Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC”
Teva Pharmaceuticals USA, Inc.
4 packages: 1 available · 2 limited · 1 unavailable · contact 800-545-8800
Reason “Other”
FDA's note “Estimated recovery: December 2028”
FDA's note “Estimated recovery: January 2027”
FDA's note “Estimated recovery: March 2027”
Eugia US LLC
2 packages: 1 available · 1 unavailable · contact 888-238-7880
Reason “Demand increase for the drug”
FDA's note “Check wholesalers for inventory”
FDA's note “On backorder. Recovery: late-October 2026. Check wholesalers for inventory”
Fresenius Kabi USA, LLC
1 package: 1 unavailable · contact 888-386-1300
Reason “Delay in shipping of the drug”
FDA's note “Next release December 2026. Check wholesalers for inventory.”
Teyro Labs
4 packages: 4 available · contact Natco Pharma USA LLC: (201)786-6500
FDA's note “Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)”
Avyxa Pharma, LLC
2 packages: 2 available · contact 877-595-7337; customerservice@avyxa.com
To be discontinued (6)
- Discontinued Feb. 20, 2026Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)Ingenus Pharmaceuticals LLC
- Discontinued Feb. 20, 2026Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)Ingenus Pharmaceuticals LLC
- Discontinued June 1, 2026Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)Teyro Labs
- Discontinued June 1, 2026Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)Teyro Labs
- Discontinued June 1, 2026Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)Teyro Labs
- Discontinued June 1, 2026Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)Teyro Labs
Every entry as FDA lists it (35)
Current shortage (29)
Accord Healthcare Inc.
Contact: 866-941-7875, option 2
- UnavailableCarboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)Reason: Discontinuation of the manufacture of the drug
Related information: Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
First posted April 28, 2023 · updated Nov. 2, 2026 - UnavailableCarboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)Reason: Discontinuation of the manufacture of the drug
Related information: Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
First posted April 28, 2023 · updated Nov. 2, 2026 - UnavailableCarboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)Reason: Discontinuation of the manufacture of the drug
Related information: Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
First posted April 28, 2023 · updated Nov. 2, 2026 - UnavailableCarboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)Reason: Discontinuation of the manufacture of the drug
Related information: Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
First posted April 28, 2023 · updated Nov. 2, 2026
Avyxa Pharma, LLC
Contact: 877-595-7337; customerservice@avyxa.com
- AvailableKyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)First posted April 28, 2023 · updated Nov. 2, 2026
- AvailableKyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)First posted April 28, 2023 · updated Nov. 2, 2026
Eugia US LLC
Contact: 888-238-7880
- UnavailableCarboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)Reason: Demand increase for the drug
Related information: On backorder. Recovery: late-October 2026. Check wholesalers for inventory
First posted April 28, 2023 · updated Oct. 19, 2026 - AvailableCarboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)Related information: Check wholesalers for inventory
First posted April 28, 2023 · updated Oct. 19, 2026
Fresenius Kabi USA, LLC
Contact: 888-386-1300
- UnavailableCarboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)Reason: Delay in shipping of the drug
Related information: Next release December 2026. Check wholesalers for inventory.
First posted April 28, 2023 · updated Nov. 3, 2026
Gland Pharma Limited
Contact: Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270
- AvailableCarboplatin, Injection, 150mg/15mL (NDC 54288-165-01)Related information: Distributed by BPI Labs, LLC
First posted April 28, 2023 · updated Oct. 21, 2026 - Limited AvailabilityCarboplatin, Injection, 450mg/45mL (NDC 54288-166-01)Reason: Demand increase for the drug
Related information: Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC
First posted April 28, 2023 · updated Oct. 21, 2026 - UnavailableCarboplatin, Injection, 50mg/5mL (NDC 54288-164-01)Reason: Discontinuation of the manufacture of the drug
Related information: Discontinued; Distributed by BPI Labs, LLC
First posted April 28, 2023 · updated Oct. 21, 2026 - Limited AvailabilityCarboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)Reason: Demand increase for the drug
Related information: Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC
First posted April 28, 2023 · updated Oct. 21, 2026
Hospira, Inc., a Pfizer Company
Contact: 844-646-4398
- UnavailableCarboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)Reason: Other
Related information: Next Delivery: December 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026 - Limited AvailabilityCarboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)Reason: Other
Related information: Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026 - UnavailableCarboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)Reason: Other
Related information: Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026 - Limited AvailabilityCarboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)Reason: Other
Related information: Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026 - Limited AvailabilityCarboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)Reason: Demand increase for the drug
Related information: Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027
First posted April 28, 2023 · updated Nov. 9, 2026 - UnavailableCarboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)Reason: Other
Related information: Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026 - Limited AvailabilityCarboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)Reason: Other
Related information: Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026 - UnavailableCarboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)Reason: Other
Related information: Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
First posted April 28, 2023 · updated Nov. 9, 2026
Teva Pharmaceuticals USA, Inc.
Contact: 800-545-8800
- Limited AvailabilityCarboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)Reason: Other
Related information: Estimated recovery: December 2028
First posted April 28, 2023 · updated Nov. 2, 2026 - UnavailableCarboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)Reason: Other
Related information: Estimated recovery: January 2027
First posted April 28, 2023 · updated Nov. 2, 2026 - AvailableCarboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)First posted April 28, 2023 · updated Nov. 2, 2026
- Limited AvailabilityCarboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)Reason: Other
Related information: Estimated recovery: March 2027
First posted April 28, 2023 · updated Nov. 2, 2026
Teyro Labs
Contact: Natco Pharma USA LLC: (201)786-6500
- AvailableCarboplatin, Injection, 150 mg/15 mL (NDC 69339-365-15)Related information: Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)
First posted April 28, 2023 · updated Oct. 20, 2026 - AvailableCarboplatin, Injection, 450 mg/45 mL (NDC 69339-366-45)Related information: Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)
First posted April 28, 2023 · updated Oct. 20, 2026 - AvailableCarboplatin, Injection, 50 mg/5 mL (NDC 69339-364-05)Related information: Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)
First posted April 28, 2023 · updated Oct. 20, 2026 - AvailableCarboplatin, Injection, 600 mg/60 mL (NDC 69339-367-60)Related information: Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)
First posted April 28, 2023 · updated Oct. 20, 2026
To be discontinued (6)
Ingenus Pharmaceuticals LLC
Contact: 866-321-5031
- Discontinued Feb. 20, 2026Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)Related information: Discontinuation of the manufacture of the drug
First posted Feb. 20, 2026 · updated Feb. 20, 2026 - Discontinued Feb. 20, 2026Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)Related information: Discontinuation of the manufacture of the drug
First posted Feb. 20, 2026 · updated Feb. 20, 2026
Teyro Labs
Contact: Apotex Inc.: 800-706-5575
- Discontinued June 1, 2026Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)Related information: Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
First posted June 1, 2026 · updated June 1, 2026 - Discontinued June 1, 2026Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)Related information: Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
First posted June 1, 2026 · updated June 1, 2026 - Discontinued June 1, 2026Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)Related information: Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
First posted June 1, 2026 · updated June 1, 2026 - Discontinued June 1, 2026Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)Related information: Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
First posted June 1, 2026 · updated June 1, 2026
Data provided by the U.S. Food and Drug Administration through openFDA, as of Nov. 12, 2026; FDA's drug shortage database can be newer. openFDA's own note on this data: "Do not rely on openFDA to make decisions regarding medical care." This is not medical advice: ask your pharmacist or doctor before changing or stopping a medicine.